News
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
11h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
On May 18, Evanston Township High School launched more than 940 graduates at commencement at Northwestern University’s ...
A new wave of COVID-19 cases, driven by the JN.1 Omicron sub-variant, is emerging in parts of Asia, raising global concerns.
Explore more
29mon MSN
The JN.1 variant is a newer version of the coronavirus that comes from the Omicron BA.2.86 family. It was first found in ...
At present, government data shows 257 active COVID-19 cases across various states in the country, with most of them coming ...
7h
Inquirer.net on MSNDOH: COVID cases in PH declining amid spike in other Asean countriesHealth Secretary Teodoro Herbosa has assured Filipinos that there is still no reason to be alarmed despite the fresh wave of ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
The Ministry of Health and Family Welfare reviews the recent COVID-19 surge in Singapore and Hong Kong. India reports 257 ...
What sets JN.1 apart is a unique mutation in the spike protein — the part of the virus that binds to human cells. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results